latestage

The Eli Lilly logo is shown on one of the company's offices in San Diego, California, September 17, 2020.Mike Blake | ReutersAn Eli Lilly experimental drug helped patients lose about 26% of their weight on average following extended use or…

Indian startups secured a total of $447 million in funding this week across 20 rounds, according to data provided by market intelligence firm Tracxn, a 124% surge compared to the same period last year, when startups had raised $188 million…

Late-stage deal value in the US plummeted to a 21-quarter low, hitting only $11.6 billion across 99 funds in the first quarter of 2023, according to a report from PitchBook-NVCA Venture Monitor.Nationwide, there were an estimated 3,888…

Amid the ongoing funding winter, investment in Indian startups managed to cross the $1 billion dollar mark in March, on the back of late-stage funding in eyewear seller Lenskart and Walmart-owned fintech PhonePe. The total funding for…

Funding activity in the Indian startup ecosystem saw another muted week. A total of $87 million was raised across 12 rounds between March 18 and March 24, according to data provided by market intelligence firm Tracxn.ETtechThis represents…

The funding slowdown in India, which is paired with a large amount of unallocated dry powder, could lead to investors taking a "wait-and-see" approach on late-stage startups — with expectations of fair valuations and a keen eye on unit…

Famed Silicon Valley startup accelerator Y Combinator (YC) announced on Tuesday that it will wind down its late-stage investment fund. YC said in a blog post that late-stage funding was different from early stage and was becoming a…

The chemistry of planet formation has fascinated researchers for decades because the chemical reservoir in protoplanetary discs -- the dust and gas from which planets form -- directly impacts planet composition and potential for life. New…

US drugmaker Pfizer said on Thursday (Dec 29) its experimental gene therapy for the treatment of hemophilia B, a rare inherited blood disorder, met its main goal in a late-stage study. Data from the study showed that a single dose of the…

A new way of reprogramming our immune cells to shrink or kill off cancer cells has been shown to work in the otherwise hard to treat and devastating skin cancer, melanoma. The University of Bristol-led discovery, published in Advanced…